This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Chu Nantes, National Institute of Health and Medical Research, The University of Nantes. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 18 
1 out of 1,853 
1 out of 156 
Years Active: 2020
Title: Aude Segaliny: Innovator in Antibody Development
Introduction
Aude Segaliny is a prominent inventor based in Dammarie, France. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Aude Segaliny holds 1 patent for her invention of anti IL-34 antibodies. This patent pertains to novel antibodies or antigen-binding fragments that specifically bind to the cytokine IL-34 with high affinity. The disclosure includes methods for obtaining these antibodies and outlines their therapeutic applications, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Aude has worked with esteemed institutions such as Chu Nantes and the National Institute of Health and Medical Research. Her experience in these organizations has allowed her to develop her expertise in antibody research and therapeutic applications.
Collaborations
Aude Segaliny has collaborated with notable professionals in her field, including Régis Brion and Dominique Heymann. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Aude Segaliny is a trailblazer in the field of antibody development, with her innovative work paving the way for new therapeutic options. Her contributions to biotechnology are invaluable, and her patent on anti IL-34 antibodies exemplifies her dedication to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile